Daily FNArena News

The weekly spot uranium price has seen its biggest jump in two years while analysts see a possible supply deficit ahead.

Yesterday FNArena showed the market has a range of opinions on Wotif.com and Commonwealth Bank has added to the discussion with a Sell rating on the stock.

Stockbrokers argue whether shares in Wotif.com are now a bargain or instead still too expensive. Earnings growth from H2 FY11 onwards will be key.

Brokers believe ASX shareholders have been offered a great deal from the SGX but what is the honest chance of approval being granted?

RBS Morgans remains positive on the outlook for shares in biotech Acrux.

ING Investment Management’s latest survey shows Australian investor sentiment is improving, though investors are yet to actually invest more in equities.

The TechWizard believes AUD/USD is poised to reach parity anytime soon now.

Both Credit Suisse and Morgan Stanley have added coverage on Australian companies today, while Macquarie has cut iSoft from its coverage universe.

Woodside’s quarterly production and revenues surprised to the upside but further delays are likely at Pluto-1 and Pluto-2 gas exploration is proving disappointing.

Stockbroker Moelis expects continued solid earnings growth from recruitment group Talent2 following a meeting with management.